How to define the best efficacy parameters for migraine
Open Access
- 1 June 1997
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 17 (17_suppl) , 6-9
- https://doi.org/10.1177/0333102497017s1703
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Oral sumatriptan-associated transmural myocardial infarctionNeurology, 1995
- The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraineThe Lancet, 1995
- Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptanNeurology, 1995
- Cardiovascular Adverse Reactions to SumatriptanCNS Drugs, 1995
- SumatriptanDrugs, 1994
- Sumatriptan for the Treatment of Migraine Attacks-A Review of Controlled Clinical TrialsCephalalgia, 1993
- Transmural myocardial infarction with sumatriptanThe Lancet, 1993
- Headache recurrence after subcutaneous sumatriptanThe Lancet, 1992
- Sumatriptan An Oral Dose-Defining StudyEuropean Neurology, 1991
- The Clinical Pharmacology, Pharmacokinetics and Metabolism of SumatriptanEuropean Neurology, 1991